2.4.0.8000280 - Disclosure - 5. Global Diagnostic License: Investment in Laboratories (Tables)truefalsefalse1false falsefalseD130101_130630http://www.sec.gov/CIK0001024048duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_TableTextBlockSupplementAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Tables/Schedules2false 2fil_InvestmentInLaboratoriesfil_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00  <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr align="left"> <td width="638" colspan="3" valign="top" style='width:6.65in;padding:0in 5.4pt 0in 5.4pt'> Investment in Laboratories </td> </tr> <tr align="left"> <td width="520" valign="top" style='width:390.25pt;padding:0in 5.4pt 0in 5.4pt'>   </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'>   </td> <td width="97" valign="top" style='width:72.75pt;padding:0in 5.4pt 0in 5.4pt'>   </td> </tr> <tr align="left"> <td width="520" valign="top" style='width:390.25pt;padding:0in 5.4pt 0in 5.4pt'> November 18, 2011 (initial value) </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> $ </td> <td width="97" valign="top" style='width:72.75pt;padding:0in 5.4pt 0in 5.4pt'> 1,000,000 </td> </tr> <tr align="left"> <td width="520" valign="top" style='width:390.25pt;padding:0in 5.4pt 0in 5.4pt'> Share of losses up to December 31, 2012 </td> <td width="21" valign="top" style='width:15.8pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>   </td> <td width="97" valign="top" style='width:72.75pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'> (87,424) </td> </tr> <tr align="left"> <td width="520" valign="top" style='width:390.25pt;padding:0in 5.4pt 0in 5.4pt'> December 31, 2012 </td> <td width="21" valign="top" style='width:15.8pt;border:none;padding:0in 5.4pt 0in 5.4pt'>   </td> <td width="97" valign="top" style='width:72.75pt;border:none;padding:0in 5.4pt 0in 5.4pt'> 912,576 </td> </tr> <tr align="left"> <td width="520" valign="top" style='width:390.25pt;padding:0in 5.4pt 0in 5.4pt'> Share of gain for the six months ended June 30, 2013 </td> <td width="21" valign="top" style='width:15.8pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'>   </td> <td width="97" valign="top" style='width:72.75pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'> 5,646 </td> </tr> <tr align="left"> <td width="520" valign="top" style='width:390.25pt;padding:0in 5.4pt 0in 5.4pt'> June 30, 2013 </td> <td width="21" valign="top" style='width:15.8pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'> $ </td> <td width="97" valign="top" style='width:72.75pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'> 918,222 </td> </tr> </table>falsefalsefalsenonnum:textBlockItemTypenaSchedule of Investment in Laboratories.No definition available.false0Investment in Laboratoriesfalse5. Global Diagnostic License: Investment in Laboratories (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.panaceaglobalinc.com/20130630/role/idr_Disclosure5GlobalDiagnosticLicenseInvestmentInLaboratoriesTables12